Session date: 
03/20/2019 - 12:10pm to 1:00pm

Aref Al-Kali, M.D.
Associate Professor of Oncology
 

Locations:

  • Geffen Auditorium (Live)
  • Broadcast to SMH Alfred M-459 and Baldwin 4-316/Baldwin 4-516
  • Mayo Clinic Health System in Waycross (Video Conference)

Lunch available outside Geffen Auditorium and SMH Alfred M-459 on a first-come, first-serve basis.

Learning Objectives:

  • Use which molecular tests are needed for diagnosis of myeloid neoplasms
  • Generate differential diagnosis for abnormal labs and tests needed for work up
  • Manage myeloid cases preoperatively and specific goals needed for each disease
  • Learn novel concepts in myeloid diseases and its impact on clinical practice

Financial Disclosures:

  • Grant.Research Support - Ariad, Astex, BMS, Celgene, Daiichi-Sankyo, GSK, H3 Biomedicine, Medimmune, Novartis, Onconova

Off Label/Investigational Uses:

  • Astellas - Gilternitinib
  • Agios - Ivosedinib

For disclosure information regarding Mayo Clinic School of Continuous Professional Development accreditation review committee member(s), please go here to review disclosures.

Presenter: 
Aref Al-Kali, M.D.
Where did the idea for the course originate?: 
Minnesota
Please login or register to take this course.
Where did the idea for the course originate?: 
Minnesota